AzTrials
AzTrials

SpeechNCT05954520

Effects of Nonlinear Signal Processing Algorithms on Speech Perception

A study testing Tympan in people with Speech and Hearing Loss, Sensorineural, run by Indiana University at 1 site in United States.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

The purpose of this study is to investigate the effect of nonlinear signal processing algorithms on speech perception. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Speech, Hearing Loss, Sensorineural, Hearing Aids
What is being tested?
Tympan
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
1 siteUnited States
Study dates
1 Aug 2023to 9 Jun 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Between the ages of 18 and 65
  • Native speaker of English
  • Have bilateral, symmetric sensorineural hearing loss that is less than 75 decibels (dB) Hearing Level (HL) at 1000 Hz and below.

Who cannot join

  • Subjects with normal hearing, mixed hearing loss, or asymmetric sensorineural hearing loss.
  • Subjects who younger than 18 or older than 65.
  • Subjects who are not native speakers of English.
  • Subjects with thresholds more than 70 dB HL at 2000 Hz and below

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Health Sciences Building

    Bloomington, Indiana, 47408

Other trials in United States

About this study

The purpose of this study is to investigate the effect of nonlinear signal processing algorithms on speech perception.

Read the detailed description

In this study, we are interested in how nonlinear algorithms influence speech perception.

Nonlinear algorithms are used within hearing aids and personal sound amplifiers to provide comfort to the listener. One of these algorithms provides amplification (gain) in a manner that depends on the level of the input sound.: Low-level sounds are amplified much more than high-level sounds. This type of amplification makes sounds more comfortable for listeners, but also distorts incoming sounds. To determine the effect of these algorithms on speech understanding, we will evaluate the following factors on speech perception, within the context of these algorithms:

  • The input Signal-to-Noise ratio (SNR) to the algorithm (3 different SNRs)
  • The type of background noise (20 people talking or 2 people talking)
  • Algorithm settings (slow and fast - whether changes to gain applied to fluctuating input sounds occurs quickly or slowly)

To address our questions, we are using a wearable processor (Tympan) that allows for real-time processing of audio signals. The Tympan itself contains microphones, a processor, and small earpieces that include speakers. A listener can wear the earpieces, like headphones, and listen to sounds processed by the Tympan in real time. The Tympan allows us access to the algorithms and to the sounds processed by the algorithms so that we cannot algorithm behavior to speech perception.

Our study will complement existing work on speech perception and nonlinear algorithms, but our study will be the first to use a wearable processor in which the specific algorithm is known, tailored to an individual's hearing levels, and which allows for direct calculation of the output SNR. Most studies also have not measured speech perception, and this will be one of only a handful of studies with that objective.

Being tested
Tympan
Keywords
speech perception, hearing aids
Medical subject headings
Speech, Hearing Loss, Sensorineural

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • TympanDevice

    Participants will wear a prototype hearing aid (called the Tympan)

Study groups in NCT05954520
Study groupRoleWhat they receive
Perceptual measuresExperimentalPerception will be measured for different algorithm settings and environmental variables (type of noise and signal-to-noise ratio)
Receives: Device: Tympan

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Speech understanding

    Percent words correct will be measured

    Measured: 1-2 hours

Secondary outcomes (1)
  1. Preference

    Algorithm preference will be measured for each experimental condition

    Measured: 15 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Jul 2023
  2. Study start1 Aug 2023
  3. Primary completion9 Jun 2025
  4. Study completion9 Jun 2025

Why it stopped: The student conducting this work took a job at another institution and is no longer continuing this study.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05954520
Sponsor's protocol ID
18675
Status last verified
Jun 2025
First submitted
13 Jul 2023
Last updated
12 Jun 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Tympan in people with Speech and Hearing Loss, Sensorineural, run by Indiana University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 12 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Speech understanding (time frame: 1-2 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jun 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in